Korea, Democratic People's Republic of vs Mali: Treatment success rate for patients treated for MDR-TB
Korea, Democratic People's Republic of
80.0%
in 2022
Mali
80.0%
in 2022
Korea, Democratic People's Republic of rank
50th
Mali rank
50th
Treatment success rate for patients treated for MDR-TB over time
- Korea, Democratic People's Republic of
- Mali
How they compare
Korea, Democratic People's Republic of currently reports 80.0% against 80.0% in Mali, a difference of 0.0%.
The two have swapped places 3 times across 11 shared years of data; in 2012 it was Korea, Democratic People's Republic of ahead.
Korea, Democratic People's Republic of ranks 50th and Mali ranks 50th of 163 countries.
Korea, Democratic People's Republic of has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Korea, Democratic People's Republic of | Mali | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 79.9% | 66.5% | 13.4% | Korea, Democratic People's Republic of |
| 2020s | 76.7% | 76.0% | 0.7% | Korea, Democratic People's Republic of |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Korea, Democratic People's Republic of or Mali?
- Korea, Democratic People's Republic of, at 80.0% against 80.0% in Mali as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Korea, Democratic People's Republic of and Mali?
- 0.0%, with Korea, Democratic People's Republic of ahead.
- How many years of comparable data are there for Korea, Democratic People's Republic of and Mali?
- 11 years are reported by both, from 2012 to 2022.
- How do Korea, Democratic People's Republic of and Mali rank globally for treatment success rate for patients treated for mdr-tb?
- Korea, Democratic People's Republic of ranks 50th and Mali ranks 50th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.